Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay?

Adakveo and Oxbryta could be revolutionary treatments, but each costs about $100,000 per year and must be taken for life.
By BY GINA KOLATA from NYT Health https://ift.tt/3520H25
via IFTTT
Drugs (Pharmaceuticals), Health Insurance and Managed Care, Sickle Cell Anemia, Prices (Fares, Fees and Rates), Stroke, Clinical Trials, Hemoglobin
Source New York Times
Làm đẹp Blog 247